For 10 years the book series Ac ute Leukemias has been providing updates on the rapid progress being made internationally concerning this group of diseases. The fifth volume mainly addressed experimental approaches, but the present issue presents both therapeutic and prognostic aspects of the most recent results from major multicenter clinical trials. Additional chapters report new trends in leukemia cell biology,the monitoring of minimal residual disease, and secondary leukemias, as well as new antileukemic drugs, antimicrobial strategies, and the use of cytokines. The combined efforts…mehr
For 10 years the book series Acute Leukemias has been providing updates on the rapid progress being made internationally concerning this group of diseases. The fifth volume mainly addressed experimental approaches, but the present issue presents both therapeutic and prognostic aspects of the most recent results from major multicenter clinical trials. Additional chapters report new trends in leukemia cell biology,the monitoring of minimal residual disease, and secondary leukemias, as well as new antileukemic drugs, antimicrobial strategies, and the use of cytokines. The combined efforts against acute leukemias described in this book explain the recent improvements in the outcome of patients suffering from acute leukemias.
Produktdetails
Produktdetails
Haematology and Blood Transfusion Hämatologie und Bluttransfusion 38
Leukemia Cell Biology: Cytogenetics.- Leukemia Cell Biology: Molecular Biology.- Leukemia Cell Biology: Cytokines.- Leukemia Cell Biology.- Residual Leukemia.- New Strategies: Nucleoside Analogs.- New Strategies: Idarubicin.- New Strategies Using Growth Factors: G-CSF.- New Strategies Using Growth Factors: GM-CSF, PIXY 321.- New Strategies: Antifungal Treatment.- Pharmacology.- ALL in Children.- ALL in Adults.- AML in Children.- AML in Adults.- Secondary Leukemia, Myelodysplastic Syndrome.- Supportive Care.
Leukemia Cell Biology: Cytogenetics.- Leukemia Cell Biology: Molecular Biology.- Leukemia Cell Biology: Cytokines.- Leukemia Cell Biology.- Residual Leukemia.- New Strategies: Nucleoside Analogs.- New Strategies: Idarubicin.- New Strategies Using Growth Factors: G-CSF.- New Strategies Using Growth Factors: GM-CSF, PIXY 321.- New Strategies: Antifungal Treatment.- Pharmacology.- ALL in Children.- ALL in Adults.- AML in Children.- AML in Adults.- Secondary Leukemia, Myelodysplastic Syndrome.- Supportive Care.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826